VR Logo

Neuland Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1984

Chairman: Davuluri Rama Mohan Rao

Managing Director: Davuluri Rama Mohan Rao

Group: --

Listing: NSE: NEULANDLAB, BSE: 524558

Headquarters: Hyderabad, Telangana

Website: www.neulandlabs.com

Key Facts

Market cap: R 1,775.08 Cr

Revenue (TTM): R 842.30 Cr

Earnings (TTM): R 38.42 Cr

Cash: R 54.48 Cr

Total Debt: R 259.59 Cr

Promoters' ownership: 36.25%

Liquidity: High

52 Week range: R 245.75 - 1,465.00

Face value: R10.00

Shares outstanding: 1,28,29,889

10 Years Aggregate:

  • CFO: 391.47 Cr
  • EBITDA: 686.45 Cr
  • Net Profit: 183.00 Cr

Stock Performance

Time Period Neuland Laboratories S&P BSE Healthcare* S&P BSE Small Cap*
YTD26.43-0.690.62
1 month28.00-0.393.03
3 months18.379.6520.33
1 Year185.0452.2622.53
3 Years15.8812.72-1.99
5 Years14.836.5211.21
10 Years29.9112.807.31
As on 27-Jan-2021 *As on 25-Jan-2021
Year Neuland Laboratories S&P BSE Small Cap S&P BSE Healthcare
2020161.5332.1161.45
2019-12.17-6.85-3.55
2018-48.48-23.41-5.89
2017-13.5159.640.49
201629.881.77-12.88
201559.176.7615.06
201461.6869.2447.43

Review & Analysis